Abstract
Purpose:
Pheochromocytomas are rare tumors and biochemically silent ones with normal catecholamine levels are even rarer. Up to date, biochemically inactive pheochromocytomas are poorly investigated. We aimed to systematically assess the pre- and peri-operative characteristics and the outcomes of patients with these tumors who had been treated and followed-up in 2 tertiary centers.
Methods:
Clinical, laboratory and imaging data, treatment outcomes and follow-up of biochemically silent pheochromocytoma patients were recorded.
Results:
Ten patients (5 men) [median age at diagnosis 52.5 years (24–72)] were included. Adrenal masses were incidentally discovered in all patients except from one who presented with pheochromocytoma-related manifestations. Twenty-four-hour urine metanephrine and normetanephrine levels were in the low-normal, normal and high-normal range in 4, 4 and 2 patients and in 1, 6 and 3 patients, respectively. Tumors were unilateral [median size 46 mm (17–125)] and high density on pre-contrast CT imaging or high signal intensity on T2-weighted MRI scans were found in all cases. Pre-operatively, 5 patients were treated with phenoxybenzamine [median total daily dose 70 mg (20–100)]. Intra-operatively, 4 patients developed hypertension requiring vasodilator administration and 8 developed hypotension; vasoconstrictors were required in 5 cases. One patient, not pre-operatively treated with phenoxybenzamine, developed Takotsubo cardiomyopathy. During a median 24-month (12–88) follow-up period, one patient had disease progression.
Conclusions:
The majority (90%) of patients with biochemically silent pheochromocytomas developed hemodynamic instability during adrenal surgery. In patients with biochemically silent adrenal lesions and a high suspicion index for pheochromocytoma based on tumor imaging characteristics, pre-operative alpha-blockade treatment may be advisable.
Similar content being viewed by others
References
A.M.A. Berends, E. Buitenwerf, R.R. de Krijger, N. Veeger, A.N.A. van der Horst-Schrivers, T.P. Links, M.N. Kerstens, Incidence of pheochromocytoma and sympathetic paraganglioma in the Netherlands: A nationwide study and systematic review. Eur. J. Intern. Med. 51, 68–73 (2018). https://doi.org/10.1016/j.ejim.2018.01.015
A.A. Leung, J.L. Pasieka, M.D. Hyrcza, D. Pacaud, Y. Dong, J.M. Boyd, H. Sadrzadeh, G.A. Kline, Epidemiology of pheochromocytoma and paraganglioma: population-based cohort study. Eur. J. Endocrinol. 184(1), 19–28 (2021). https://doi.org/10.1530/eje-20-0628
L.M. Gruber, R.P. Hartman, G.B. Thompson, T.J. McKenzie, M.L. Lyden, B.M. Dy, W.F. Young, I. Bancos, Pheochromocytoma Characteristics and Behavior Differ Depending on Method of Discovery. J. Clin. Endocrinol. Metab. 104(5), 1386–1393 (2019). https://doi.org/10.1210/jc.2018-01707
R. Clifton-Bligh, Diagnosis of silent pheochromocytoma and paraganglioma. Expert Rev. Endocrinol. Metab. 8(1), 47–57 (2013). https://doi.org/10.1586/eem.12.76
M. Mannelli, J.W. Lenders, K. Pacak, G. Parenti, G. Eisenhofer, Subclinical phaeochromocytoma. Best practice & research. Clin. Endocrinol. Metab. 26(4), 507–515 (2012). https://doi.org/10.1016/j.beem.2011.10.008
G.N. Zografos, A.K. Farfaras, E. Kassi, D.N. Vaidakis, A. Markou, G. Kaltsas, G. Piaditis, Laparoscopic resection of pheochromocytomas with delayed vein ligation. Surgical Laparosc., Endosc. percutaneous Tech. 21(2), 116–119 (2011). https://doi.org/10.1097/SLE.0b013e318213bb1f
C. Aggeli, A.M. Nixon, C. Parianos, G. Vletsis, L. Papanastasiou, A. Markou, T. Kounadi, G. Piaditis, G.N. Zografos, Surgery for pheochromocytoma: A 20-year experience of a single institution. Hormones (Athens, Greece) 16(4), 388–395 (2017). https://doi.org/10.14310/horm.2002.1759
J.H. Kim, H.C. Lee, S.J. Kim, S.B. Yoon, S.H. Kong, H.W. Yu, Y.J. Chai, J.Y. Choi, K.E. Lee, K.W. Lee, S.K. Min, C.S. Shin, K.J. Park, Perioperative hemodynamic instability in pheochromocytoma and sympathetic paraganglioma patients. Sci. Rep. 11(1), 18574 (2021). https://doi.org/10.1038/s41598-021-97964-3
B.S. Aprill, A.J. Drake 3rd, D.H. Lasseter, K.M. Shakir, Silent adrenal nodules in von Hippel-Lindau disease suggest pheochromocytoma. Ann. Intern. Med. 120(6), 485–487 (1994). https://doi.org/10.7326/0003-4819-120-6-199403150-00006
N.B. Tütüncü, O. Gedik, Adrenal incidentaloma: report of 33 cases. J. surgical Oncol. 70(4), 247–250 (1999). 10.1002/(sici)1096-9098(199904)70:4<247::aid-jso9>3.0.co;2-o
S.K. Kota, S.K. Kota, S. Panda, K.D. Modi, Pheochromocytoma: an uncommon presentation of an asymptomatic and biochemically silent adrenal incidentaloma. Malays. J. Med. Sci.: MJMS. 19(2), 86–91 (2012)
M.G. Heavner, L.S. Krane, S.M. Winters, M. Mirzazadeh, Pheochromocytoma diagnosed pathologically with previous negative serum markers. J. surgical Oncol. 112(5), 492–495 (2015). https://doi.org/10.1002/jso.24031
N. Sundahl, S. Van Slycke, N. Brusselaers, A rare case of clinically and biochemically silent giant right pheochromocytoma: case report and review of literature. Acta chirurgica Belgica. 116(4), 239–242 (2016). https://doi.org/10.1080/00015458.2016.1139838
H. Turkova, T. Prodanov, M. Maly, V. Martucci, K. Adams, J. Widimsky Jr., C.C. Chen, A. Ling, E. Kebebew, C.A. Stratakis, T. Fojo, K. Pacak, Characteristics and outcomes of metastatic SDHB and sporadic pheochromocytoma/paraganglioma: An national institutes of health study. Endocr. Pract.: Off. J. Am. Coll. Endocrinol. Am. Assoc. Clin. Endocrinologists. 22(3), 302–314 (2016). https://doi.org/10.4158/ep15725.or
L. Petramala, A. Concistrè, F. Olmati, V. Saraceno, G. Iannucci, A. Ciardi, G. De Toma, C. Letizia, Silent Adrenal Pheochromocytoma Coexistent with Corticomedullary Hyperplasia: A Case Incidentally Discovered. Eur. J. case Rep. Intern. Med. 4(10), 000714 (2017). https://doi.org/10.12890/2017_000714
S. Kumar, K.M. Parmar, D. Aggarwal, K. Jhangra: Simple adrenal cyst masquerading clinically silent giant cystic pheochromocytoma. BMJ case reports 12(9) (2019). https://doi.org/10.1136/bcr-2019-230730
R.Z. El-Doueihi, I. Salti, M. Maroun-Aouad, A. El Hajj, Bilateral biochemically silent pheochromocytoma, not silent after all. Urol. Case Rep. 24, 100876 (2019). https://doi.org/10.1016/j.eucr.2019.100876
K.M.A. Dreijerink, J.A. Rijken, C.J. Compaijen, H. Timmers, A.N.A. van der Horst-Schrivers, R.S. van Leeuwaarde, P.S. van Dam, C.R. Leemans, E. van Dam, C. Dickhoff, C.J. Dommering, P. de Graaf, G.J.C. Zwezerijnen, P. van der Valk, C.W. Menke-Van der Houven van Oordt, E.F. Hensen, E.P.M. Corssmit, E.M.W. Eekhoff, Biochemically Silent Sympathetic Paraganglioma, Pheochromocytoma, or Metastatic Disease in SDHD Mutation Carriers. J. Clin. Endocrinol. Metab. 104(11), 5421–5426 (2019). https://doi.org/10.1210/jc.2019-00202
A. Montebello, E. Ceci Bonello, M. Giordano Imbroll, M. Gruppetta, Biochemically silent phaeochromocytoma presenting with non-specific loin pain. BMJ case reports 14(8) (2021). https://doi.org/10.1136/bcr-2021-244258
H.P.H. Neumann, W.F. Young Jr., C. Eng, Pheochromocytoma and Paraganglioma. N. Engl. J. Med. 381(6), 552–565 (2019). https://doi.org/10.1056/NEJMra1806651
J.W. Lenders, Q.Y. Duh, G. Eisenhofer, A.P. Gimenez-Roqueplo, S.K. Grebe, M.H. Murad, M. Naruse, K. Pacak, W.F. Young Jr,, Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab. 99(6), 1915–1942 (2014). https://doi.org/10.1210/jc.2014-1498
M. Isaacs, P. Lee,, Preoperative alpha-blockade in phaeochromocytoma and paraganglioma: is it always necessary. Clin. Endocrinol. 86(3), 309–314 (2017). https://doi.org/10.1111/cen.13284
H. Groeben, B.J. Nottebaum, P.F. Alesina, A. Traut, H.P. Neumann, M.K. Walz,, Perioperative α-receptor blockade in phaeochromocytoma surgery: an observational case series. Br. J. Anaesth. 118(2), 182–189 (2017). https://doi.org/10.1093/bja/aew392
P.F. Plouin, L. Amar, O.M. Dekkers, M. Fassnacht, A.P. Gimenez-Roqueplo, J.W. Lenders, C. Lussey-Lepoutre, O. Steichen, European Society of Endocrinology Clinical Practice Guideline for long-term follow-up of patients operated on for a phaeochromocytoma or a paraganglioma. Eur. J. Endocrinol. 174(5), G1–g10 (2016). https://doi.org/10.1530/eje-16-0033
H.J. Timmers, K. Pacak, T.T. Huynh, M. Abu-Asab, M. Tsokos, M.J. Merino, B.E. Baysal, K.T. Adams, G. Eisenhofer,, Biochemically silent abdominal paragangliomas in patients with mutations in the succinate dehydrogenase subunit B gene. J. Clin. Endocrinol. Metab. 93(12), 4826–4832 (2008). https://doi.org/10.1210/jc.2008-1093
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no competing interests.
Ethics approval
The study was registered with and approved by the ‘G. Gennimatas’ General Hospital of Athens ethics committee and its reporting conforms to the Guidelines for Good Clinical Practice, Declaration of Helsinki.
Informed consent
Informed consent was obtained from all patients participating in the study.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Fountas, A., Kanti, G., Glycofridi, S. et al. Pre- and peri-operative characteristics, complications and outcomes of patients with biochemically silent pheochromocytomas; a case series. Endocrine 78, 570–579 (2022). https://doi.org/10.1007/s12020-022-03182-w
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12020-022-03182-w